Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial
about
Molecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue.Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsiesThe Quantitative Criteria Based on the Fractal Dimensions, Entropy, and Lacunarity for the Spatial Distribution of Cancer Cell Nuclei Enable Identification of Low or High Aggressive Prostate Carcinomas.An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.Gleason scoring at a comprehensive cancer center: what's the difference?Interobserver variability in the pathological assessment of radical prostatectomy specimens: findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.On the relationship between tumor structure and complexity of the spatial distribution of cancer cell nuclei: a fractal geometrical model of prostate carcinoma.Variation between specialist uropatholgists in reporting extraprostatic extension after radical prostatectomy.Computer-Aided Image Analysis and Fractal Synthesis in the Quantitative Evaluation of Tumor Aggressiveness in Prostate CarcinomasAssessment of pathological response to therapy using lipid mass spectrometry imaging.miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathways.Influence of pathologist experience on positive surgical margins following radical prostatectomy.Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy.Subspecialty surgical pathologist's performances as triage pathologists on a telepathology-enabled quality assurance surgical pathology service: A human factors study.On complexity and homogeneity measures in predicting biological aggressiveness of prostate cancer; Implication of the cellular automata model of tumor growth.High-grade prostatic adenocarcinoma present in a single biopsy core is associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy.The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy.Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.Central pathology review of radical prostatectomy specimens does make a difference not only with grade.The performance of the new prognostic grade and stage groups in conservatively treated prostate cancer.
P2860
Q31043717-8CCB9F1C-570E-42F6-A014-CA2F4593EE02Q36245147-F39A9E33-BE9D-4CAE-A72B-C1BEF4A66D3DQ36568781-BDC0B98B-118B-42D2-8C89-26698C7ACA31Q36610246-4F9F817A-5AC5-4187-A782-8E42914FB198Q37490037-3F017145-E414-497F-A9A7-42C51C6605B2Q38125826-52CE8969-0088-46D8-9856-1730F68D7906Q38302346-9F05B2BB-138B-4385-9C15-887F67BD3AFEQ38384899-0661178B-0313-4A73-AFE5-EA4794F7D281Q38446649-7762EA00-7C26-437D-9FC2-007AE10F4031Q38795676-B5CFFDFE-4E7E-43BA-A551-BB3511B7ACD5Q38870815-2B9EE860-5FDD-4040-84B2-EA9D697051F0Q39182622-3C2562F9-EE68-4514-893F-C748EA8832D1Q39544440-8A04075D-F262-432E-AECF-709814218D33Q39823876-BC2DFB98-17FA-4B05-A22A-228FBDA90195Q40209916-3A7B81FC-5CAC-410A-AECE-FB5F600083EFQ40437169-A8E2B805-A804-4D54-8532-FC19D4C24FDAQ41766827-BFC594B3-503D-4958-A526-95E6A3F8D4B9Q43561673-5FE2A566-8D3D-4C4E-B288-8B079CA63803Q45879396-E3073A5F-4872-43A4-BFAE-8051EB26F5FAQ50142583-0C4FB783-746B-442B-836E-BB35942E4340Q52679869-BAA13654-D556-437D-AA4C-F15E87A31520
P2860
Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interobserver variability in h ...... 1 multinational clinical trial
@en
Interobserver variability in h ...... multinational clinical trial.
@nl
type
label
Interobserver variability in h ...... 1 multinational clinical trial
@en
Interobserver variability in h ...... multinational clinical trial.
@nl
prefLabel
Interobserver variability in h ...... 1 multinational clinical trial
@en
Interobserver variability in h ...... multinational clinical trial.
@nl
P2093
P2860
P1433
P1476
Interobserver variability in h ...... 1 multinational clinical trial
@en
P2093
George J Netto
Jonathan I Epstein
Mario Eisenberger
TAX 3501 Trial Investigators
P2860
P304
P356
10.1016/J.UROLOGY.2010.08.031
P407
P577
2010-12-13T00:00:00Z